The overexpression of FYN in breast cancer has been documented, and thus the proliferative phenotype of breast cancer disappears upon inhibition of FYN expression, suggesting that FYN is a downstream molecule of PTPN23 mediating breast carcinogenesis [62]. Here, FYN is linked to breast carcinoma.